SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001739104-23-000009
Filing Date
2023-05-09
Accepted
2023-05-09 09:08:41
Documents
72
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q elan-20230331.htm   iXBRL 10-Q 1295180
2 EX-31.1 ex311elanco-20230331xceoce.htm EX-31.1 10296
3 EX-31.2 ex312elanco-20230331xcfoce.htm EX-31.2 10300
4 EX-32 ex32elanco-20230331xsectio.htm EX-32 8877
10 elan-20230331_g1.jpg GRAPHIC 68307
  Complete submission text file 0001739104-23-000009.txt   6142246

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT elan-20230331.xsd EX-101.SCH 40593
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT elan-20230331_cal.xml EX-101.CAL 61120
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT elan-20230331_def.xml EX-101.DEF 195966
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT elan-20230331_lab.xml EX-101.LAB 502042
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT elan-20230331_pre.xml EX-101.PRE 333913
66 EXTRACTED XBRL INSTANCE DOCUMENT elan-20230331_htm.xml XML 922773
Mailing Address 2500 INNOVATION WAY GREENFIELD IN 46140
Business Address 2500 INNOVATION WAY GREENFIELD IN 46140 877-352-6261
Elanco Animal Health Inc (Filer) CIK: 0001739104 (see all company filings)

IRS No.: 825497352 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38661 | Film No.: 23900237
SIC: 2834 Pharmaceutical Preparations